Announcements Trials
Browse Landscape

Phase

Phase 1 28Phase 1/2 22Phase 2 14Phase 3 4Phase 2/3 1

Status

Recruiting 16Completed 14Active not recruiting 14Not yet recruiting 6Terminated 4Unknown 2

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4

Conditions

Leukemia, Myeloid, Acute 4Neoplasms 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Terminated × venetoclax × Clear all
NCT03926624 2026-01-22

Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage

Delta-Fly Pharma, Inc.

Phase 3 Terminated
167 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04161885 2025-10-06

VIALE-T

AbbVie

Phase 3 Terminated
465 enrolled
Other hematologic neoplasm

Neoplasms, Leukemia, Myeloid, Acute

NCT05079230 2025-04-04

ENHANCE-3

Gilead Sciences

Phase 3 Terminated
378 enrolled 29 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04778397 2025-02-05

ENHANCE-2

Gilead Sciences

Phase 3 Terminated
258 enrolled 25 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡